Browse classification

Loading Please Wait
A:HUMAN NECESSITIES  
 A61: HEALTH; AMUSEMENT; MEDICAL OR VETERINARY SCIENCE; HYGIENE  
  A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agent employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toilet purposes A61K; preparation of ozone C01B13/10)  
   A61L2300/00: Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices  
   A61L2300/10: containing or releasing inorganic materials  
   A61L2300/102: . . Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates  
   A61L2300/104: . . . Silver, e.g. silver sulfadiazine  
   A61L2300/106: . . Halogens or compounds thereof, e.g. iodine, chlorite  
   A61L2300/108: . . Elemental carbon, e.g. charcoal  
   A61L2300/11: . . Peroxy compounds, peroxides, e.g. hydrogen peroxide  
   A61L2300/112: . . Phosphorus-containing compounds, e.g. phosphates, phosphonates  
   A61L2300/114: . . Nitric oxide, i.e. NO  
   A61L2300/20: containing or releasing organic materials  
   A61L2300/202: . . with halogen atoms, e.g. triclosan, povidone-iodine  
   A61L2300/204: . . with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines  
   A61L2300/206: . . . Biguanides, e.g. chlorohexidine  
   A61L2300/208: . . . Quaternary ammonium compounds  
   A61L2300/21: . . Acids  
   A61L2300/212: . . . Peroxy acids, peracids  
   A61L2300/214: . . . Amino acids  
   A61L2300/216: . . with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups  
   A61L2300/22: . . Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes  
   A61L2300/222: . . . Steroids, e.g. corticosteroids  
   A61L2300/224: . . containing metals, e.g. porphyrins, vitamin B12  
   A61L2300/23: . . Carbohydrates  
   A61L2300/232: . . . Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides  
   A61L2300/236: . . . Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin  
   A61L2300/25: . . Peptides having up to 20 amino acids in a defined sequence  
   A61L2300/252: . . Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines  
   A61L2300/254: . . . Enzymes, proenzymes  
   A61L2300/256: . . . Antibodies, e.g. immunoglobulins, vaccines  
   A61L2300/258: . . Genetic materials, DNA, RNA, genes, vectors, e.g. plasmids  
   A61L2300/30: . . Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera  
   A61L2300/40: characterised by a specific therapeutic activity or mode of action  
   A61L2300/402: . . Anaestetics, analgesics, e.g. lidocaine  
   A61L2300/404: . . Biocides, antimicrobial agents, antiseptic agents  
   A61L2300/406: . . . Antibiotics  
   A61L2300/408: . . . Virucides, spermicides  
   A61L2300/41: . . Anti-inflammatory agents, e.g. NSAIDs  
   A61L2300/412: . . Tissue-regenerating or healing or proliferative agents  
   A61L2300/414: . . . Growth factors  
   A61L2300/416: . . Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus  
   A61L2300/418: . . Agents promoting blood coagulation, blood-clotting agents, embolising agents  
   A61L2300/42: . . Anti-thrombotic agents, anticoagulants, anti-platelet agents  
   A61L2300/422: . . Anti-atherosclerotic agents  
   A61L2300/424: . . Anti-adhesion agents  
   A61L2300/426: . . Immunomodulating agents, i.e. cytokines, interleukins, interferons  
   A61L2300/428: . . Vitamins, e.g. tocopherol, riboflavin  
   A61L2300/43: . . Hormones, e.g. dexamethasone  
   A61L2300/432: . . Inhibitors, antagonists (A61L2300/402 - A61L2300/43 take precedence)  
   A61L2300/434: . . . of enzymes  
   A61L2300/436: . . . of receptors  
   A61L2300/438: . . Antigens  
   A61L2300/44: . . Radioisotopes, radionuclides  
   A61L2300/442: . . Colorants, dyes  
   A61L2300/45: . . Mixtures of two or more drugs, e.g. synergistic mixtures  
   A61L2300/452: . . Lubricants  
   A61L2300/60: characterised by a special physical form  
   A61L2300/602: . . Type of release, e.g. controlled, sustained, slow  
   A61L2300/604: . . . Biodegradation  
   A61L2300/606: . . Coatings  
   A61L2300/608: . . . having two or more layers  
   A61L2300/61: . . . . containing two or more active agents in different layers  
   A61L2300/62: . . Encapsulated active agents, e.g. emulsified droplets  
   A61L2300/622: . . . Microcapsules  
   A61L2300/624: . . . Nanocapsules  
   A61L2300/626: . . . Liposomes, micelles, vesicles  
   A61L2300/63: . . Crystals  
   A61L2300/64: . . Animal cells  
   A61L2300/80: characterised by a special chemical form  
   A61L2300/802: . . Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants